- Home
- GFF vs RARE Comparison
GFF vs RARE Comparison
Compare GFF & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GFF
- RARE
- Stock Information
- Founded
- GFF 1959
- RARE 2010
- Country
- GFF United States
- RARE United States
- Employees
- GFF N/A
- RARE N/A
- Industry
- GFF Building Products
- RARE Biotechnology: Pharmaceutical Preparations
- Sector
- GFF Industrials
- RARE Health Care
- Exchange
- GFF Nasdaq
- RARE Nasdaq
- Market Cap
- GFF 3.2B
- RARE 3.5B
- IPO Year
- GFF N/A
- RARE 2014
- Fundamental
- Price
- GFF $77.87
- RARE $39.91
- Analyst Decision
- GFF Strong Buy
- RARE Strong Buy
- Analyst Count
- GFF 4
- RARE 15
- Target Price
- GFF $99.00
- RARE $90.53
- AVG Volume (30 Days)
- GFF 320.7K
- RARE 1.1M
- Earning Date
- GFF 08-06-2025
- RARE 07-31-2025
- Dividend Yield
- GFF 0.92%
- RARE N/A
- EPS Growth
- GFF 30.60
- RARE N/A
- EPS
- GFF 4.82
- RARE N/A
- Revenue
- GFF $2,551,604,000.00
- RARE $590,689,000.00
- Revenue This Year
- GFF N/A
- RARE $18.94
- Revenue Next Year
- GFF $3.02
- RARE $28.93
- P/E Ratio
- GFF $16.15
- RARE N/A
- Revenue Growth
- GFF N/A
- RARE 33.46
- 52 Week Low
- GFF $55.01
- RARE $29.59
- 52 Week High
- GFF $86.73
- RARE $60.37
- Technical
- Relative Strength Index (RSI)
- GFF 71.02
- RARE 63.02
- Support Level
- GFF $71.79
- RARE $35.51
- Resistance Level
- GFF $72.09
- RARE $39.87
- Average True Range (ATR)
- GFF 1.68
- RARE 1.56
- MACD
- GFF 0.91
- RARE 0.17
- Stochastic Oscillator
- GFF 96.85
- RARE 89.45
About GFF Griffon Corporation
Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products: is a provider of branded consumer and professional tools; residential, industrial and commercial fans; home storage and organization products; and Home and Building Products conducts its operations through Clopay Corporation (Clopay). Clopay is the manufacturer and marketer of garage doors and rolling steel doors in North America. The company generates a majority of its revenue from the Home and Building Products segment. Operates in USA, Europe, Canada, Australia, and Others.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.